The relevance of this mechanism as a source of modified autoantigens in RA is supported by the detection of many of the same proteins in ionomycin- or perforin-treated neutrophils as in the synovial fluid of RA patients, exemplified by NCF1 and vimentin. The gene discussed is VIM; the disease is rheumatoid arthritis.